ABSTRACT Bronchoalveolar lavage was carried out in 36 subjects with sarcoidosis and 20 control subjects undergoing bronchoscopy for routine diagnostic purposes. The proportion of mast cells in the lavage fluid of subjects with sarcoidosis (mean (SE) 0.84% 0.09%; p < 0.01) when compared with that of controls (mean 0.32% (0.05%); p < 0.01). This increase was greatest in subjects with positive gallium scans but was not correlated with the percentage recovery of lymphocytes or radiographic stage. Anti-IgE induced histamine release from the bronchoalveolar cells of 15 subjects with sarcoidosis was significantly increased at all effective doses of anti-IgE. This accentuation of histamine release was significantly greater in patients with positive gallium scans and correlated directly with the percentage recovery of lymphocytes (r = 0.7, p < 0.005). The dose-response curve of anti-IgE induced histamine release from bronchoalveolar cells of subjects with more than 20% of lymphocytes in the lavage cell population was significantly greater than the dose-response curves of subjects with fewer than 20% of lymphocytes and of controls.
For many years mast cells have been known to be associated with immediate hypersensitivity reactions. These cells possess a large number of high affinity receptors for IgE (reaginic) antibody and rapidly degranulate after IgE dependent immunological challenge.' More recently, however, activation of mast cells and basophils has been described in the lesions of cutaneous delayed hypersensitivity reactions.2 Two non-IgE factors produced by T lymphocytes have been shown to mediate mast cell histamine release. The first histamine releasing activity is a product of mitogen (concanavalin A) stimulated T lymphocytes that stimulate histamine release from blood basophils and dispersed human lung mast cells.3" The second, a non-immunoglobulin antigen binding factor, mediates an antigen specific mast cell degranulation.56 We have recently shown that mast cells recovered by bronchoalveolar lavage resemble mucosal mast cells in many respects.7 This subtype of mast cell is derived from bone marrow, and a T lymphocyte product, probably interleukin 3, has been shown to control the proliferation and maturation of these cells from bone marrow stem cells in rodents.8 9 Pulmonary sarcoidosis is characterised by a T lymphocyte "alveolitis," with an excess of activated T lymphocytes, high rates of spontaneous replication, and increased interleukin 2 production within the lung.1I The presence of large numbers of T lymphocytes could influence the number of mast cells present within the lung and, via the elaboration of these lymphokines, alter their function (or "activate" them). Furthermore, mast cells have been identified in lung tissue in pulmonary fibrosis of widely differing aetiologies1' 12 and increased histamine concentrations have been found in lung lavage fluid from patients with cryptogenic fibrosing alveolitis.'3 If present in increased numbers and activated, the bronchoalveolar mast cells in pulmonary sarcoidosis might be relevant to the development of lung damage and the progression to pulmonary fibrosis seen in this disease.
The aim of this study was to compare mast cells recovered by bronchoalveolar lavage from patients with sarcoidosis with bronchoalveolar mast cells from a control population. Accentuated dose-response curves occurred with equal frequency in atopic and non-atopic patients and this hyperresponsiveness to IgE dependent challenge appeared to be confined to the bronchoalveolar compartment in that the dose-response curves for histamine release induced by anti-IgE in peripheral blood leucocytes from patients with sarcoidosis and controls were similar (fig 4) . There was no significant difference in mean serum IgE concentration between subjects showing accentuation of histamine release and those with normal dose-response curves (mean 25 (7) IU/ml compared with 37 (12) IU/ml). Furthermore, there was no relationship between either the IgE concentration in the lavage fluid (when detectable) or the presence or absence of detectable IgE and the anti-IgE response before or after correction for dilution by the use of creatinine.
Discussion
This study has demonstrated the presence of increased numbers of mast cells in the bronchoalveolar lavage fluid of patients with sarcoidosis. Both the total cell recovery and the percentage of mast cells is increased. The increased recovery of mast cells was greatest in those patients with positive gallium scans and in those with radiological evidence of pulmonary lesions. The number of mast cells recovered did not, however, appear to depend on the radiological stage of the disease, neither was it correlated with the percentage of lymphocytes present in the lavage fluid recovered. Mast cells in the lavage fluid of these patients and mast cells from control patients have similar characteristics of staining and fixation and a similar histamine content per cell. Nevertheless, the response to anti-IgE was accentuated in patients with sarcoidosis, with increased release of histamine at all effective dilutions of anti-IgE. This accentuation of histamine release was significantly greater in patients with positive gallium scans and in patients in whom lymphocytes formed more than 20% of the recovered cells. In addition, in patients with sarcoidosis histamine release correlated directly with the percentage of lymphocytes within the lavage at all 97
Although low affinity IgE receptors have been found on other cell types,'1 sno human cell other than the mast cell or basophil has been shown to contain or re;ease histamine.' It is unlikely, therefore, that the accentuation of histamine release in subjects with sarcoidosis is due to the release of histamine from other cell types. Although the patients and controls are reasonably well matched there remain differences in age distribution and in smoking habit. We think it unlikely that these account for either the difference in mast cell numbers or the degree of histamine release. Three of the four patients who smoked are included among the group with accentuated histamine release and there was no difference in dose-response curves among controls when smokers and non-smokers were compared. Similarly, we have failed to detect significant differences in mast cell numbers between control smokers and non-smokers.
It is becoming increasingly apparent that T lymphocytes can modulate mast cell function. Proliferation of rodent mucosal mast cells during gastrointestinal parasitic infestation in vivo and during in vitro culture from bone marrow has been shown to be T cell dependent.'6 ' I The lymphokine concerned has been tentatively identified as interleukin 3.8 Bronchoalveolar mast cells resemble mucosal mast cells in their morphological characteristics7 and hence proliferation might be expected to be regulated by the local production of lymphokines. There are two possible explanations for the lack of correlation between numbers of lymphocytes and of mast cells in the lavage fluid. The stimulus for proliferation of broncho-alveolar mast cells may lie outside the broncho-alveolar compartment or, alternatively, a small subset of lymphocytes may be responsible for lymphokine production in patients with sarcoidosis. Interestingly, the most potent conditioned medium for the in vitro development of mucosal type mast cells is produced by cells from regional lymph nodes. during parasitic infestation."
The increased release of histamine from bronchoalveolar cells of patients with sarcoidosis is the first demonstration of differences in the mast cell response to activation in different disease states. Cells in the two groups were recovered and stimulated in exactly the same way and the differences cannot be attributed to differences in technique. Increased histamine release did not seem to be related to concentrations of IgE in the serum or lavage fluid, as concentrations of these were similar in patients and controls; neither was there any correlation between serum or lavage fluid IgE concentration and anti-IgE induced histamine release from lavage cells. The correlation between the number of bronchoalveolar lymphocytes recovered and mast cell histamine release was surprising and suggests a possible modulation of IgE dependent activation by lymphocyte factors. Several lymphokines have been described recently that can bring about mast cell and basophil degranulation. Histamine releasing activity has been found in the supernatant of mitogen stimulated peripheral blood lymphocytes.34 Histamine releasing activity has been shown to have an effect which is additive to that of anti-IgE in releasing histamine from enzymatically dispersed human lung mast cells and from peripheral blood leucocytes.4 After the extensive washing of lavage cells any histamine releasing activity produced in vivo is unlikely to persist during in vitro activation. This is supported by the low spontaneous rates of histamine release from bronchoalveolar cells of patients with sarcoidosis, suggesting low levels of spontaneous activation, which would not be the case in the presence of appreciable concentrations of histamine releasing activity. Little is known of the interactions, if any, between the antigen specific T cell factor described by Askenase and coworkers in the mouse5 and IgE dependent activation. The production of these or other lymphokines in vivo may regulate mast cell histamine release and simultaneously lead to an alteration in sensitivity to IgE dependent activation. Such an increase in the response to antiIgE may be mediated via an increase in the surface density of IgE receptors or an alteration in receptorresponse coupling. Which of these is responsible remains to be determined.
Whether an increase in mast cell numbers or accentuation of mediator release in these patients is related to the likelihood of progression to pulmonary fibrosis is uncertain. Mast cells have been identified in increased numbers within the lung in patients with fibrotic lung disorders" 12 and increased histamine has been detected in the lung lavage fluid from patients with cryptogenic fibrosing alveolitis and sarcoidosis. '3 In rat models of radiation induced pulmonary fibrosis the increase in mast cell numbers parallels the increase in numbers of fibroblasts and precedes the appearance of fibrosis. '8 No increase in mast cell numbers is seen in those animals exposed to lower doses of radiation, in which fibrosis does not develop."8 19 Similarly, after asbestos inhalation in rats mast cell number increases with increasing severity of pulmonary fibrosis.20 Furthermore, histamine has been shown to lead to proliferation of fibroblasts in vitro2' and mast cell degranulation has been shown to stimulate proliferation of fibroblast like cells in rat mesentery in vivo, an effect that appears to be mediated via the H2 receptor. 22 The lack of correlation between radiographic stage of disease and mast cell number does not necessarily weaken the hypothesis that these cells play a part in fibrogenesis. The presence of radiological scarring
